Extended-release naltrexone—an injection that decreases heavy drinking in the general population when taken in conjunction with counseling—appears to help HIV-positive individuals reduce their number of heavy drinking days too, say Yale researchers. This study was published online on Aug. 2 in AIDS and Behavior. “While we know that patients with heavy alcohol use are less